September 2, 2024 by Flinders University CDK9 is commonly over-expressed and amplified in prostate cancer. Credit: British Journal of Cancer (2024). DOI: 10.1038/s41416-024-02810-8Researchers from Flinders University and University of South Australia have unveiled a promising new strategy that could be used to treat the most aggressive forms of prostate cancer. Their study, published in British...
